Published in Medicine (Baltimore) on January 01, 2016
Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma. Medicine (Baltimore) (2017) 0.78
Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database. Oncotarget (2016) 0.76
Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study. World J Gastroenterol (2016) 0.75
Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis. Medicine (Baltimore) (2016) 0.75
Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation. Sci Rep (2017) 0.75
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. J Cancer Res Clin Oncol (2017) 0.75
Late recurrence of hepatocellular carcinoma after liver transplantation. Hepatoma Res (2017) 0.75
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer (1954) 12.77
Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis (1999) 12.31
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Updated treatment approach to hepatocellular carcinoma. J Gastroenterol (2005) 3.43
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther (2006) 2.63
The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol (2002) 2.03
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant (2010) 1.93
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90
Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg (2008) 1.65
Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46
[Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil]. Arq Gastroenterol (2007) 1.44
Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl (2001) 1.31
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.29
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol (2005) 1.28
Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl (2007) 1.27
Liver transplantation for hepatocellular carcinoma. World J Surg (1995) 1.26
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl (2001) 1.25
Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg (2001) 1.21
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Liver Transpl (2004) 1.12
Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol (2013) 1.08
Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl (2004) 1.02
Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl (2002) 0.99
Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg (2008) 0.98
The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol (2008) 0.95
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg (2003) 0.93
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant (2010) 0.93
Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg (2011) 0.92
Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience. Transplant Proc (2015) 0.89
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci (2008) 0.89
AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2012) 0.88
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. Br J Cancer (2014) 0.86
Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma. Transplant Proc (2012) 0.85
Burden of liver disease in Brazil. Liver Int (2014) 0.84
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chin Med J (Engl) (2005) 0.84
Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes. Transplant Proc (2009) 0.82
Liver transplantation for hepatocellular carcinoma: a surgical perspective. J Clin Gastroenterol (2013) 0.81
Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol (2013) 0.81
Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria. Clin Transplant (2014) 0.81
Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation (2006) 0.79
Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Transplant Proc (2012) 0.79
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Am J Transplant (2004) 0.78
Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg (2002) 0.78
Liver transplantation for patients with hepatocellular carcinoma. Transplant Proc (2004) 0.76
Nonalcoholic steatohepatitis in nondiabetic obese patients. Can J Gastroenterol (2002) 1.43
Noninvasive methods for esophageal varices prediction in cirrhotic patients: are we there yet? Gastroenterology (2013) 1.06
[Ambulatorial prevalence of hepatitis B and C markers in patients with human immunodeficiency virus infection in a general hospital]. Arq Gastroenterol (2006) 1.05
Survival benefit of liver transplantation and the effect of underlying liver disease. Surgery (2009) 0.97
Bacteremia in cirrhotic patients submitted to endoscopic band ligation of esophageal varices. Arq Gastroenterol (2004) 0.87
Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor? Ann Hepatol (2010) 0.86
[Prevalence and prognosis of spontaneous bacterial peritonitis. Experience in patients from a general hospital in Porto Alegre, RS, Brazil (1991-2000)]. Arq Gastroenterol (2003) 0.85
Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma. Ann Hepatol (2012) 0.84
Platelet count/spleen diameter ratio: can it replace endoscopy for the screening of esophageal varices in cirrhotic patients? Eur J Gastroenterol Hepatol (2012) 0.82
[Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil]. Arq Gastroenterol (2004) 0.79
Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection? World J Gastroenterol (2013) 0.79
Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis. Hepatogastroenterology (2003) 0.78
[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis]. Arq Gastroenterol (2002) 0.77
Pegylated interferon and ribavirin in real life: efficacy versus effectiveness. Hepatology (2010) 0.77
Acute hepatitis C in Brazil: results of a national survey. J Med Virol (2011) 0.77
Liver glutathione depletion after preservation and reperfusion in human liver transplantation. Acta Cir Bras (2006) 0.76
Survival and risk factors related to death in outpatients with cirrhosis treated in a clinic in Southern Brazil. Eur J Gastroenterol Hepatol (2015) 0.76
[Laparoscopic cholecystectomy in patients with liver cirrhosis]. Arq Gastroenterol (2003) 0.76
Platelet count/spleen diameter ratio: is there sufficient evidence for its use? Dig Dis Sci (2012) 0.75
Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience. Clin Transplant (2013) 0.75
The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats. Ann Hepatol (2013) 0.75
[Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis]. Arq Gastroenterol (2005) 0.75
[Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection]. Arq Gastroenterol (2007) 0.75